Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis associated 16 pseudogene (ENSG00000258971) is a genomic locus classified as a pseudogene, meaning it is a DNA sequence that resembles a gene but has lost its ability to code for a functional protein. Pseudogenes can arise through various mechanisms such as retrotransposition (yielding processed pseudogenes) or gene duplication followed by mutational inactivation. While generally considered noncoding and biologically inconsequential, some pseudogenes have been shown to exert regulatory functions at the RNA level, particularly through acting as decoys for miRNAs and possibly influencing gene expression. There is no evidence that ENSG00000258971 functions as a receptor, enzyme, or other canonical drug target, nor does it act as a biomarker or have known therapeutic relevance.
None; not a druggable target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis associated 16 pseudogene.